tiprankstipranks
Advertisement
Advertisement

Rubicon Organics Posts Record 2025 Results and Scales Up Premium Cannabis Capacity

Story Highlights
  • Rubicon Organics delivered record 2025 revenue, higher profitability, and solidified its lead in Canada’s premium cannabis market.
  • The company rapidly ramped its Cascadia facility, boosting capacity to meet strong demand and support margin and cash flow growth in 2026.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Rubicon Organics Posts Record 2025 Results and Scales Up Premium Cannabis Capacity

Claim 55% Off TipRanks

The latest update is out from Rubicon Organics ( (TSE:ROMJ) ).

Rubicon Organics reported record 2025 net revenue of $59.5 million, up 22% year over year, with adjusted EBITDA rising to $5.0 million and operations turning from a loss to a $1.8 million profit. The company strengthened its balance sheet with new equity and debt financing while maintaining solid working capital, and it reinforced its leadership in Canada’s premium cannabis category, with 1964 Supply Co. and Wildflower earning top market-share positions and multiple industry awards.

Operationally, Rubicon rapidly integrated and ramped up its Cascadia cultivation facility, now rated at 4,500 kilograms of premium cannabis and already harvesting as of February 2026, which lifts combined annual capacity across its two sites to 15,500 kilograms. Management expects this added capacity to relieve persistent supply constraints, support both domestic and international expansion, and drive margin, adjusted EBITDA, and cash flow improvements in the second half of 2026, underscoring a pivotal growth year for the company.

The most recent analyst rating on (TSE:ROMJ) stock is a Buy with a C$1.00 price target. To see the full list of analyst forecasts on Rubicon Organics stock, see the TSE:ROMJ Stock Forecast page.

Spark’s Take on ROMJ Stock

According to Spark, TipRanks’ AI Analyst, ROMJ is a Neutral.

Rubicon Organics’ stock score is primarily influenced by its financial performance, which shows improvement in revenue growth and gross profit margin but is hindered by low profitability and cash flow issues. Technical analysis indicates a lack of strong momentum, while valuation suggests the stock is reasonably priced. The absence of earnings call and corporate events data limits further insights.

To see Spark’s full report on ROMJ stock, click here.

More about Rubicon Organics

Rubicon Organics Inc. is a Canadian licensed producer focused on premium and super-premium cannabis products, including dried flower, vapes, and topicals. The company targets the higher-end segment of the adult-use cannabis market through brands such as 1964 Supply Co. and Wildflower, where it holds leading national market shares in premium flower, vapes, and topicals.

Average Trading Volume: 61,700

Technical Sentiment Signal: Sell

Current Market Cap: C$32.92M

See more insights into ROMJ stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1